History of Drug Development Solutions Center

Year Event
1955 Establishment of the first non-governmental radioisotope laboratory
1963 Release of the domestic-first radiopharmaceuticals
1965 Completion of construction of Tokai Laboratory
1971 Start of contract research business for pharmacokinetic study
1975 Completion of construction of the 2nd experiment building, Tokai Laboratory
1983 Start of contract research business for antigenicity study
Completion of construction of animal experiment building, Tokai Laboratory
1984 Host of the 1st "Progress in Pharmacokinetics" seminar
1985 Completion of construction of the 3rd experiment building, Tokai Laboratory
Host of the 2nd "Progress in Pharmacokinetics" seminar
1986 The 1st MHW (the Ministry of Health and Welfare) GLP inspection for antigenicity study: rating "A"
1987 Host of the 3rd "Progress in Pharmacokinetics" seminar
1989 The 2nd MHW GLP inspection for antigenicity study: rating "A"
1990 Host of the 4th "Progress in Pharmacokinetics" seminar
Completion of construction of the 4th experiment building, Tokai Laboratory
1993 Host of the 5th "Progress in Pharmacokinetics" seminar
The 3rd MHW GLP inspection for antigenicity study: rating "A"
1995 Start of contract research business for toxicokinetics study
Host of the 6th "Progress in Pharmacokinetics" seminar
1996 Start of contract research business for pharmacokinetic study in compliance with the GLP standard
1997 The 1st OPSR (Organization for Pharmaceutical Safety and Research) GLP review for toxicokinetics study: rating "A"
Host of the 7th "Progress in Pharmacokinetics" seminar
1999 Start of contract research business for human pharmacokinetic study using radio-labeled compounds
Renamed "ADME & Tox. Research Institute" from the former Tokai Laboratory
2000 Memorial seminar for the 35th anniversary of the ADME & Tox. Research Institute
The 2nd OPSR GLP review for toxicokinetics study: rating "A"
Business alliance with Inveresk Research group Inc.
2002 The 3rd OPSR GLP review for toxicokinetics study: rating "A"
2003 Co-host with Inveresk Research Group Inc. of "Clinical study in UK and Japan" seminar
Conclusion of GeneChip® service provider contract with Affimetrix Japan K.K.
2004 Business alliance with Institute of Accelerator Analysis Ltd.
Business alliance with PhoenixBio Co., Ltd.
2005 Memorial seminar for the 40th anniversary of the ADME & Tox. Research Institute
2007 The 1st PMDA (Pharmaceutical and Medical Device Agency) GLP review for toxicokinetics study: rating "A"
Business alliance with ICONIX Biosciences Inc.
2008 The company name was changed to "Sekisui Medical Co., Ltd."
Memorial seminar for the establishment of Sekisui Medical Co., Ltd.
Acquisition of XenoTech, LLC, an in vitro study facility in U.S.
Business alliance with Molecular Imaging Research Inc.
2010 The 2nd PMDA (Pharmaceutical and Medical Device Agency) GLP review for toxicokinetics study: rating "A"
Memorial seminar for the 45th anniversary of the ADME & Tox. Research Institute
2010 Memorial seminar for the 45th anniversary of the ADME & Tox. Research Institute
2011 Business alliance with Korea Institute of Toxicology (toxicity and enviromental study)
2012 The 3rd PMDA (Pharmaceutical and Medical Device Agency) GLP review for toxicokinetics study: rating "A"
2013 Business alliance with PWG Laboratories (stuydy using miniature pigs)
The Economy, Trade and Industry Minister Award was given for "Development and Drug Discovery Technology by utilizing Microdose Clinical Studies"
2014 Business alliance with Seoul National University Hospital DCK consulting (microdosing clinical study)
Acquisition of AAALAC Full Approval by the Association for Assessment and Accrediation of Laboratory Animal Care International
2016 Name of Division and laboratory was changed to "Drug Development Solutions Division" and "Drug Development Soutions Center", respectively
2017 Register SMCL Tokai Laboratory